doxazosin has been researched along with carbon tetrachloride in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Campos-Esparza, Mdel R; Cervantes-García, D; Elías-Flores, TG; Gerardo-Rodríguez, M; Llamas-Ramírez, RW; Muñoz-Fernández, L; Muñoz-Ortega, MH; Romero-Delgadillo, NI; Tavares-Rodríguez, Ede J; Ventura-Juárez, J | 1 |
Ding, Q; Li, Z; Xiu, AY; Zhang, CQ | 1 |
2 other study(ies) available for doxazosin and carbon tetrachloride
Article | Year |
---|---|
Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion.
Topics: Adrenergic alpha-1 Receptor Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Carbazoles; Carbon Tetrachloride; Carvedilol; Collagen Type I; Cricetinae; Doxazosin; Liver; Liver Cirrhosis; Liver Function Tests; Propanolamines; Serum Albumin; Transforming Growth Factor beta | 2016 |
Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Apoptosis; Autophagy; Carbon Tetrachloride; Cell Line; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Doxazosin; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |